Overview

Metyrapone as Additive Treatment in Major Depression

Status:
Completed
Trial end date:
2001-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether metyrapone is an effective and safe augmenting agent in the treatment of major depression.
Phase:
Phase 2
Details
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Treatments:
Metyrapone